Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
European Surgery
Erschienen in:

01.10.2015 | Original Article

Outcome of anal and rectal melanoma: has site of origin a prognostic value? Analysis of 287 patients

verfasst von: A. Ciarrocchi, R. Pietroletti, F. Carlei, G. Amicucci

Erschienen in: European Surgery | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Summary

Introduction

To investigate the prognostic role of site of origin for primary anorectal melanoma.

Methods

Data regarding patients affected by primary melanoma of the anal canal and rectum were retrieved from the surveillance, epidemiology, and end results database. Age, gender, tumor stage, tumor location, receipt of radiotherapy, and type of surgical intervention were introduced as covariates in a Cox proportional hazards regression model.

Results

Our population constituted of 177 patients affected by anal canal melanoma and 110 by rectal melanoma. Tumor stage resulted to be the only independent predictor of survival (P = 0.002; hazards ratio 1.819; 95 % confidence interval 1.255–2.636). Tumor location failed to reach statistical significance.

Conclusion

Site of origin of anorectal melanoma does not affect overall survival in patients undergoing surgery.
Vorheriger Artikel Pain perception and short-term outcomes in totally laparoscopic colonic surgery with two different fast track programs
Nächster Artikel The knowledge of Polish medical students about surgical treatment of obesity
Literatur
1.
Thibault C, Sagar P, Nivatvongs S, et al. Anorectal melanoma–an incurable disease? Dis Colon Rectum. 1997;40:661–8.CrossRefPubMed
2.
Miguel I, Freire J, Passos MJ, Moreira A. Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution. Med Oncol. 2015;32:445.CrossRefPubMed
3.
Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664–78.CrossRefPubMed
4.
Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology. 2004;6:1815–20.CrossRef
5.
Lachiewicz AM, Berwick M, Wiggins C, Thomas ME. Survival differences between patients with scalp or neck Melanoma and those with melanoma of other sites in the surveillance, epidemiology, and end results (SEER) program. Arch Dermatol. 2008;144:515–21.CrossRefPubMed
6.
Smyth EC, Flavin M, Barbi A, et al. Memorial Sloan-Kettering Cancer Center (MSKCC) single institutional vulvovaginal mucosal melanoma (VVMM) experience from 1995 to 2010. Eur J Cancer. 2011;47:S661.CrossRef
7.
Keller DS, Thomay AA, Gaughan J, Olszanski A, et al. Outcomes in patients with mucosal melanomas. J Surg Oncol. 2013;8:516–20.CrossRef
8.
Cagir B, Whiteford MH, Topham A, Rakinic J, Fry RD. Changing epidemiology of anorectal melanoma. Dis Colon Rectum. 1999;42:1203–8.CrossRefPubMed
9.
10.
11.
12.
Droesch JT, Flum DR, Mann GN. Wide local excision or abdominoperineal resection as the initial treatment for anorectal melanoma? Am J Surg. 2005;189:446–9.CrossRefPubMed
13.
Yeh JJ, Shia J, Hwu WJ, Busam KJ, et al. The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006;244:1012–7.PubMedCentralCrossRefPubMed
14.
Belli F, Gallino GF, Vullo S L, Mariani L, et al. Melanoma of the anorectal region: the experience of the National Cancer Institute of Milano. Eur J Surg Oncol. 2009;35:757–62.CrossRefPubMed
15.
Meguerditchian AN, Meterissian SH, Dunn KB. Anorectal melanoma: diagnosis and treatment. Dis Colon Rectum. 2011;54:638–44.CrossRefPubMed
16.
Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010;97:98–103.CrossRefPubMed
17.
Iddings DM, Fleisig AJ, Chen SL, Faries MB, et al. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients? Ann Surg Oncol. 2010;17:40–4.PubMedCentralCrossRefPubMed
18.
Podnos YD, Tsai NC, Smith D, Ellenhorn JD. Factors affecting survival in patients with anal melanoma. Am Surg. 2006;72:917–20.PubMed
Metadaten
Titel
Outcome of anal and rectal melanoma: has site of origin a prognostic value? Analysis of 287 patients
verfasst von
A. Ciarrocchi
R. Pietroletti
F. Carlei
G. Amicucci
Publikationsdatum
01.10.2015
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 5/2015
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-015-0348-2

Weitere Artikel der Ausgabe 5/2015

Retroperitoneal necrotizing fasciitis secondary to Fournier’s gangrene

  • Case Report

Surgery, limos and shine keep things going

  • Editorial

Hand-assisted laparoscopic surgery for left sided colorectal cancer: is quality of surgery related with experience?

  • Original Article

Transanal endoscopic microsurgery in treatment of small rectal T1 high-risk, T2 and T3 carcinomas combined with radiochemotherapy

  • Original Article

The complex interplay between Notch signaling and Snail1 transcription factor in the regulation of epithelial–mesenchymal transition (EMT)

  • Review

The assay and clinical significance of serum thymidine kinase 1 in patients with colorectal carcinoma

  • Original Article